Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha L Bucktrout

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Genome Medicine|November 1, 2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back againSamantha L Bucktrout, Jeffrey A Bluestone, Fred Ramsdell
The AAPS Journal|January 5, 2020
Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 DiabetesJason H Williams, Chandrasekhar Udata, Bishu J Ganguly, et al.
Nature Medicine|September 20, 2022
Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
Nature Medicine|February 5, 2024
Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
JCI Insight|December 20, 2019
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetesKevan C Herold, Samantha L Bucktrout, Xiao Wang, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
International Journal of Cancer|February 6, 2019
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinomaAdriaan A van Beek, Guoying Zhou, Michail Doukas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Characterization and Comparison of GITR Expression in Solid TumorsLuis Vence, Samantha L Bucktrout, Irina Fernandez Curbelo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Genome Medicine|November 1, 2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back againSamantha L Bucktrout, Jeffrey A Bluestone, Fred Ramsdell
The AAPS Journal|January 5, 2020
Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 DiabetesJason H Williams, Chandrasekhar Udata, Bishu J Ganguly, et al.
Nature Medicine|September 20, 2022
Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
Nature Medicine|February 5, 2024
Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
JCI Insight|December 20, 2019
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetesKevan C Herold, Samantha L Bucktrout, Xiao Wang, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
International Journal of Cancer|February 6, 2019
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinomaAdriaan A van Beek, Guoying Zhou, Michail Doukas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Characterization and Comparison of GITR Expression in Solid TumorsLuis Vence, Samantha L Bucktrout, Irina Fernandez Curbelo, et al.
Pageof 1